Antibody-based approach to high-volume genotyping for MIC-1 polymorphism

Area of Science:

• Biochemistry
• Genetics
• Immunology

Background:

• Macrophage inhibitory cytokine-1 (MIC-1) is a TGF-beta superfamily member with two known alleles (MIC-1 H and MIC-1 D) differing by a single nucleotide polymorphism.
• These allelic variations result in amino acid changes (histidine to aspartic acid) that may affect protein function and detection.

Purpose of the Study:

• To develop and validate a novel antibody-based assay for determining MIC-1 serum phenotype and genotype.
• To assess the frequency of MIC-1 alleles and genotypes in a population of adult blood donors.

Main Methods:

• Development of monoclonal antibodies with differential affinity for MIC-1 H and MIC-1 D alleles.
• Establishment of a PCR-RFLP method for MIC-1 genotyping.
• Validation of antibody-based and PCR-RFLP assays against DNA sequencing.
• Application of the validated assay to genotype 261 adult blood donors.

Main Results:

• The antibody-based assay demonstrated 100% concordance with DNA sequencing.
• The frequencies of MIC-1 genotypes in blood donors were HH (54%), HD (39%), and DD (7%).
• The developed assay is suitable for high-throughput, automated clinical laboratory use.

Conclusions:

• A novel, reliable antibody-based assay can accurately determine MIC-1 serum genotype.
• This assay provides an efficient method for population-based genetic studies of MIC-1.
• Understanding MIC-1 allele frequencies has implications for research in TGF-beta superfamily biology and related diseases.